| Drug Name: | Clonazepam |
| Manufacturer: | Qualitest Pharmaceuticals |
| Other Info: | Manufactured for:QUALITEST PHARMACEUTICALSHuntsville, AL 358118181959R12/07-R2 |
| Clinical Trials: | |
Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV.
Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks.The efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the DSM-IIIR category of panic disorder (see CLINICAL PHARMACOLOGY:Clinical Trials).Panic disorder (DSM-IV) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes:(1) palpitations, pounding heart or accelerated heart rate;(2) sweating;(3) trembling or shaking;(4) sensations of shortness of breath or smothering;(5) feeling of choking;(6) chest pain or discomfort;(7) nausea or abdominal distress;(8) feeling dizzy, unsteady, lightheaded or faint;(9) derealization (feelings of unreality) or depersonalization (being detached from one-self);(10) fear of losing control;(11) fear of dying;(12) paresthesias (numbness or tingling sensations);(13) chills or hot flushes.The effectiveness of clonazepam in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials.
The physician who elects to use clonazepam for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient (seeDOSAGE AND ADMINISTRATION).Clonazepam should not be used in patients with a history of sensitivity to benzodiazepines, nor in patients with clinical or biochemical evidence of significant liver disease.
It may be used in patients with open angle glaucoma who are receiving appropriate therapy but is contraindicated in acute narrow angle glaucoma.